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Localization of PDGF a-receptor in the developing and mature human
kidney. Using in situ hybridization and immunocytochemistry we describe
the renal localization of the PDGF a-receptor. PDGF a-receptor mRNA
was uniformly present in human metanephric kidney in interstitial cells
and vascular arcades that course through the blastema. PDGF a-receptor
mRNA was present in some mesangial structures in early glomeruli, but
was largely lost as glomeruli matured. It was present in adventitial
fibroblasts, but usually not in vascular smooth muscle cells or endothelial
cells of the fetal vasculature. This pattern persisted in adult kidneys, with
extensive expression of mRNA by interstitial cells and only occasional
expression by mesangial cells. All in situ hybridization findings were
corroborated by immunocytochemistry. Double immunolabeling con-
firmed the rare expression of the PDGF a-receptor protein by vascular
smooth muscle cells and the absence of its expression by endothelial cells.
Given that both PDGF A- and B-chain can promote smooth muscle cell
and fibroblast migration and proliferation and that both signal through the
PDGF a-receptor, these data suggest that PDGF a-receptor may play
important roles in the early vasculogenesis of the fetal kidney as well as in
the pathogenesis of renal interstitial fibrosis.
There is now a considerable body of evidence that PDGF is an
important mediator of many aspects of renal pathophysiology.
Studies of cultured cells, animal models of disease, mammalian
development, and human biopsy material have shown that PDGF
mediates important mesangial responses to injury including: cell
proliferation and migration [1—6]; it is essential for normal
development of the mesangium [7, 8]; it may regulate prolifera-
tion of interstitial fibroblasts and modify the phenotype and
activity of these cells during interstitial injury [9—11]; and PDGF
is implicated in the development of arterial neointimal develop-
ment in chronic vascular rejection, analogous to its apparent role
in atherosclerotic and restenotic arterial injury [12—14].
The bulk of the studies in the kidney have focused on activity
and localization of PDGF B-chain and the PDGF /3-receptor [10,
15—19]. Biologically active PDGF exists as a dimer composed of
any of the three possible combinations of two isoforms of this
molecule: PDGF A and B chain [reviewed in 20, 21]. The receptor
for PDGF also functions as a dimer, and can be composed of any
Received for publication September 9, 1996
and in revised form November 22, 1996
Accepted for publication November 25, 1996
© 1997 by the International Society of Nephrology
of three possible combinations of two isoforms known as PDGF
a- and 3-receptor. While PDGF (3-receptor subunit binds only
PDGF B-chain with high affinity, the PDGF a-receptor subunit
may bind either chain of PDGF [20, 21]. Data about the sites of
expression of both the PDGF a- and 13-receptor are necessary to
achieve a comprehensive understanding of how PDGF-AA,
PDGF-AB, or PDGF-BB may function in renal development and
renal pathophysiology.
The localization of PDGF A and B chains and PDGF /3-recep-
tor have been previously characterized in developing and mature
human kidneys as well as in renal diseases [10, 16—19, 22, 23]. In
contrast, little information is currently available on the localiza-
tion of PDGF a-receptor in adult kidney and none on its
expression in metanephric renal development. The only studies to
investigate PDGF a-receptor in normal human mature kidney
reported that expression of PDGF a-receptor could either not be
detected [24] or strictly mirrored that of PDGF /3-receptor but
was rather low compared to the /3-receptor [23]. In the current
study, we have re-assessed these controversial data and describe
the localization of PDGF a-receptor mRNA and protein in the
developing and mature human kidney. Our data provide a basis
for further mechanistic understanding of the role of the PDGF
system in human development and disease.
Methods
Tissue selection
Human fetal kidneys (N = 26) were obtained fresh from tissue
examined after therapeutic abortions. Twelve of these (estimated
gestational age 54 to 81 days) were fixed in 10% neutral buffered
formalin and processed and embedded in paraffin according to
conventional techniques. Specimens of twenty of the fetal kidneys
(estimated gestational age 75 to 105 days) were fixed in methyl
Carnoy's solution [16] and paraffin embedded. In addition to these
fetal kidneys, we also investigated normal appearing human
mature kidneys (N 22), obtained fresh from uninvolved por-
tions of kidneys surgically resected for localized renal cell carci-
noma. Portions of these tissues were fixed in methyl Carnoy's
solution, buffered formalin and other portions were fixed in
paraformaldehyde or acetone and then snap frozen as described
[16]. Four micrometer sections of all specimens were stained with
the PAS reagent for light microscopy and evaluation of the overall
morphology.
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Fig. 1. Western blotting of cell lysates for expression of the PDGF a-receptor
using (A) the PDGF (R)-A 951 antibody or (B) an equivalent concentration
of irrelevant rabbit IgG. Cell lysates are: Lane 1, growth arrested human
fetal arterial smooth muscle cells; lane 2, growth arrested smooth muscle
cells from adult human aorta; lane 3, growth arrested human lung
fibroblasts; lane 4, growth arrested human lung fibroblasts stimulated for
six hours with PDGF-AA; lane 5, growth arrested human microvascular
neonatal endothelial cells; lane 6, proliferating microvascular neonatal
endothelial cells.
Antibodies
PDGF a-receptor. PDGF (R)-A 951 (Santa Cruz Biotechnology
Inc., Santa Cruz, CA, USA) is an affinity-purified rabbit polyclonal
antibody raised against a GST fusion protein construct containing
PDGF a-receptor sequences corresponding to amino acid resi-
dues 951-1089 of the carboxy terminus of the human PDGF
a-receptor. This antibody recognized PDGF a-receptor in ace-
tone-fixed, frozen and methyl Carnoy's fixed, paraffin-embedded
sections.
The second antibody utilized was a murine monoclonal IgG1
antibody to human PDGF a-receptor (Genzyme Diagnostics,
Cambridge, MA, USA). The antibody specifically binds to PDGF
a-receptor subunit and is non-reactive with PDGF 13-receptor
[25]. This antibody was non-reactive with paraffin-embedded
material but recognized PDGF a-receptor in acetone-fixed, fro-
zen sections.
Further antibodies against the PDGF a-receptor utilized in this
study included rabbit polyclonal antibodies 1890 and 2025 against
the extracellular domain of the mouse PDGF a-receptor, ex-
pressed as a fusion protein with glutathione-S-transferase. Both
antibodies recognized PDGF a-receptor in methyl Carnoy's fixed,
Table 1. Expression of PDGF a-receptor in fetal human kidney
Site Immunohistochemistry In situ hybridization
Metanephric neg. neg.
blastema
Glomerular neg. neg.
vesicles
Early mesangial stalk +, + in hilar and mesangial
glomerular otherwise neg. regions
differentiation
(comma,
S-stage)
Differentiated neg. to rare + occasionally +
glomeruli
Ureteric buds, neg. neg.
tubules
Interstitial + (mci. adventitial +
cells cells and
prominently
around
glomerular
capsules and
tubules)
Vasculature + in vascular
arcades,
+ occasionally
in vascular
smooth
muscle cells,
+ occasional
in internal
elastic
membrane;
neg. in endothelial
cells
+ in vascular arcades,
occasionally + in
vascular smooth
muscle cells,
neg. in endothelial
cells
paraffin-embedded sections as well as acetone-fixed frozen sec-
tions.
Smooth muscle cell marker. Murine monoclonal antibody 1A4
(Dako Corp., Carpinteria, CA, USA) has been characterized by
tissue immunohistochemistry and Western blotting [26], and has
been previously demonstrated to recognize smooth muscle a-actin
in methyl Carnoy's fixed tissues [16, 27].
Endothelial cell marker. Ulex europaeus agglutinin I (Vector
Labs, Burlingame, CA, USA) is a lectin that labels human
endothelial cell surfaces, type 0 red blood cells and cells of
collecting ducts and has been utilized previously to delineate renal
vascular endothelium [16, 28, 29].
Immunohistochemistiy
Immunohistochemistry was performed on methyl Carnoy's
fixed, paraffin embedded tissues following a standard avidin-biotin
complex (ABC) method. Briefly, sections were deparaffinized in
xyiene and rehydrated in graded ethanols. Endogenous peroxi-
dase was blocked by incubation in 3% hydrogen peroxide. The
sections were then incubated for one hour with the primary
antibody diluted in PBS plus 1% bovine serum albumin. Following
washes in PBS, the sections were sequentially incubated with
biotinylated goat-anti-rabbit or horse anti-mouse antibody (Vec-
tor Labs), the ABC-Elite reagent (Vector Labs) and finally
3,3'-diaminobenzidine (DAB; with nickel chloride enhancement)
was used as the chromogen. Sections were counterstained with
methyl green, dehydrated and coverslipped.
Frozen sections of acetone or paraformaldehyde fixed tissue
were hydrated in PBS, blocked with 0.3% hydrogen peroxide and
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Fig. 2. Immunocytochemical demonstr tion of PDGF a-receptor in human
fetal kidney. (A) Low power view of a fetal kidney showing expression of
the receptor in the renal capsule, vascular a cades within the renal
blastema (arrows), mesangial areas of immat re glomeruli ( rrowhead)
but not mature (m) glomeruli, the glomer lar capsules and the renal
interstitium, in particular that adjacent to tubules (magnification X100).
(B) High power view f A showing PDGF a-receptor expression in a
vascula  arcade (arrowhead), the cells invagi ating into an immature
glomerulus (arrow) and the renal interstit um, in particular that of the
glomerular capsule and adjacent to tubuli (X400). (C) PDGF a-receptor
is expressed at the leading edge of cells invaginating a glomerul s (arrow),
a vascular arcad  (arrowhead) and around a ureteric bud (bu) but not in
the adjacent early glomerular vesicle (X400). (D) PDGF a-receptor
expression is mostly lost in mature g omeruli, while positive staining is
pres nt in the interstitium, in particular the adventi a surrounding a small
arterial vessel (a) nd tubules. The media and intima of the sel do not
exp ss PDGF a-recep r (x400). (E) In a large arterial vessel PDGF
a- eceptor is confined to the advcntitia and the area of the internal elastic
membrane (arrow; X400).
washed in PBS. The sections were then incubated with the
primary antibody, and subsequently processed as above using a
streptavidin-biotin immunoperoxidase method, counterstained
with methyl green, dehydrated and cover-slipped.
For all samples, negative controls for the immunohistochemical
procedures consisted of substitution of the primary antibody with
irrelevant murine monoclonal antibodies or non-immune rabbit
antibody or PBS.
Double labeling immunohistochemistiy
Methyl Carnoy's fixed, paraffin embedded tissues were pre-
pared for immunocytochemistry as described above. The slides
were then sequentially incubated with the PDGF (R)-A 951
antibody against PDGF a-receptor, biotinylated goat anti-rabbit
IgG (Vector), the ABC-Elite reagent (Vector Labs) and finally
DAB with nickel enhancement to give a black reaction product.
Peroxidase activity was then blocked again with 3% hydrogen
peroxide. Following this, the sections were incubated sequentially
with murine monoclonal antibody against a-smooth muscle actin,
alkaline phosphatase conjugated rabbit anti-mouse IgG antibody
and the alkaline phosphatase substrate kit I (Vector) plus 1 mi
levamisole (Sigma) which yields a red reaction product. After
washing and counterstaining with methyl green, the sections were
dehydrated, cover-slipped and viewed.
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Fig. 3. m stration of PDGF cs eptor mRNA i  human fetal kidney by
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Table 2. Expression of PDGF a-receptor in mature human kidney
Site Immunohistochemistry In situ hybridization
Glomeruli occasionally + in
mesangial areas neg.
in epithelial cells
occasionally + in
mesangial areas, neg.
in epithelial cells
Tubules neg. in all segments neg. in all segments
Interstitium + in cortical and
medullary interstitial
cells (occasional
prominent staining
around the
glomerular capsule
and tubules)
occasionally + in
cortical and medullary
interstitial cells
Vessels + in adventitia,
occasionally + in
media neg. in intima
+ in adventitia,
neg. in media
and intima
In the case of double labeling for PDGF a-receptor and
endothelial cells, incubation with the PDGF (R)-A 951 antibody
was followed by peroxidase-conjugated goat anti-rabbit antibody
(Zymed, San Francisco, CA, USA) and DAB without nickel
enhancement yielding a brown reaction product. Following a
repeat peroxidase block, sections were sequentially incubated with
Ulex europaeus agglutinin I, biotinylated goat anti-Ulex euro-
paeus agglutinin I antibody (Vector), ABC Elite reagent (Vector)
and the Vector VIP substrate kit, which yields a purple reaction
product. The final steps were identical to those described above.
Controls for the double labels were done by substitution of the
first or second primary antibody with PBS in which cases no
double label was observed.
Western blotting
To confirm the specificity of the antibody PDGF (R)-A 951
employed for immunohistochemistry, Western blotting was per-
formed using lysates from various cell lines (see below). All cell
lines were grown under similar conditions. In each case, 5 million
cells were centrifuged and the resulting cell pellet was lysed in 1
ml of SDS containing sample buffer. Thirty microliters of lysate
were used for each of the Western blots. Lysates were electro-
phoresed on a 6% SDS gel and then blotted onto polyvinylidene
difluoride membranes. The blots were blocked with 5% BSA in
PBS for one hour at 37°C and then incubated with PDGF (R)-A
951 antibody or an equal concentration of normal rabbit IgG
diluted in PBS containing 0.1% BSA for two hours at room
temperature. After washing, the blots were incubated with alka-
line phosphatase conjugated goat anti-rabbit IgG antibody (Dako)
for one hour. The blots were then visualized with 5-bromo-4-
chloro-3-indolylphosphate-nitro blue tetrazolium.
The following cell lines were used:
(1) Human lung fibroblasts (a kind gift from S. Narayanan,
Dept. Pathology, University of Washington, Seattle, WA, USA)
were grown in RPMI medium (Gibco, Gaithersburg, MD, USA),
supplemented with 10% fetal calf serum, 100 U/ml penicillin-
streptomycin, 2 mtvi glutamine, 10 mtvi HEPES and 5 tg/ml insulin
(all from Sigma). After reaching confluency, the cells were growth
arrested in medium with 0.5% fetal calf serum and incubated 24
hours. Finally, the cells were stimulated with either 100 ng/ml
PDGF-AA (a kind gift of C. Hart, ZymoGenetics, Seattle, WA,
USA; dissolved at 1 mg/ml in 0.1 N acetic acid) or vehicle for
further six hours. The cells were then scraped off the tissue culture
flasks, washed once with PBS and the content of each 75 ml tissue
culture flask was lysed in 1 ml sample buffer (0.05 M Tris, pH 6.8,
2% SDS, 10% glycerol, 0.025% bromphenol blue and 5% 13-mer-
captoethanol). Cell lysates were sheared ten times through a 25G
needle, placed in a 95°C heating block for five minutes, centri-
fuged for 20 minutes at 12,000 rpm and 30 d were then
electrophoresed on the SDS gel.
(2) Human fetal arterial smooth muscle cells and smooth
muscle cells obtained from an adult human aorta were kind gifts
of C. Giachelli (Dept. of Pathology, University of Washington).
The cells were grown to confluency, growth arrested for 24 hours
and then lysed as described for the fibroblasts.
(3) Human microvascular neonatal endothelial cells were pur-
chased from Clonetics (San Diego, CA, USA). The cells were
grown to confluency in MCDB 131 medium, supplemented with
10% fetal calf serum, 100 U/ml penicillin-streptomycin, 250 ig/ml
amphotericin B, 2 mM glutamine (all from Gibco), 20 tgfml
heparin (Sigma) and 50 g/ml endothelial cell growth supplement
(Biomedical Technologies Inc., Stoughton, MA, USA) using
gelatine-coated tissue culture flasks. Twenty-four hours prior to
lysis cells were either switched to serum-free medium or contin-
ued to be maintained in medium with 10% fetal calf serum. Lysis
was carried out as described above, except that the content of two
75 ml flasks was lysed in 0.5 ml buffer. Again, 30 .d of these lysates
were electrophoresed on the SDS gel.
Molecular probe
A 1718-bp fragment (nucleotides 76 to 1794 of the human
PDGF a-receptor sequence) was cloned in both directions into
pGEM3zf (+). This construct was linearized and transcribed into
an antisense or sense riboprobe using reagents from Promega
(Madison, WI, USA), except [35S]-UTP, which was obtained from
New England Nuclear (Boston, MA, USA). The transcription
reaction mixture contained 1 jg of PDGF a-receptor cDNA
(sense or antisense), 250 j.Ci of [35SJ-UTP, 500 tmol!liter each of
ATP, CTP and GTP, 40 U of RNAsin, 10 mmol/liter dithiothre-
itol, 40 mmol/liter Tris and 10 U of either 5P6 or T7 polymerase.
After 75 minutes at 37°C, the template DNA was digested by
adding 1 U of DNAse (Promega) and incubating at 37°C for an
additional 15 minutes. Free nucleotides were separated with a
Sephadex G-50 column. The collected fraction containing labeled
probe was then ethanol precipitated and subjected to limited
alkaline hydrolysis [30] to obtain fragments of approximately 200
bp. After hydrolysis, the probe was again precipated, resuspended
in nuclease free water containing 10 mmol dithiothriotol and
stored at —20°C. Probes were used within 48 hours.
In situ hybridization
Fetal and adult kidney tissue which had been fixed in 10%
formalin and embedded in paraffin was deparaffinized following
standard protocol. The sections were washed with 0.5 X standard
saline citrate (SSC) (1 x SSC = 150 mrvi NaCl, 15 m Na citrate,
pH 7.0) and digested with proteinase K (1 tg/ml; Sigma Chemical
Co., St. Louis, MO, USA) in RNase A (Promega) buffer for 40
minutes at 37°C. Several 0.5 X SSC washes were followed by
prehybridization for two hours in 50 j.d of prehybridization buffer
(0.3 M NaCl, 20 mM Tris pH 8.0, 5 mtvi EDTA, 1 X Denhardt's
solution, 10% dextran sulfate, 10 mrvi DTT). The hybridizations
were started by adding 500,000 cpm of 35S-labeled riboprobe in 50
,.d of prehybridization buffer and allowed to proceed overnight at
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Fig. 4. Immunocytochemical demonstration of PDGF a-receptor in human
mature kidney. A. Low power view of a mature kidney showing expression
of the receptor in renal interstitial tissue only (magnification X 100). B. No
glomerular expression of PDGF a-receptor is present in tubules or in the
glomerulus illustrated, while prominent interstitial staining is noted
(x400). C. No expression of PDGF a-receptor is present in the endothe-
hum or media of an artery (a) or in endothehial cells of a small vein (v).
Prominent expression of the receptor is noted in the arteriolar adventitia
and the interstitium (X400).
Fig. 5. A. Double immunolabeling fbr PDGF a-receptor expression (brown
Stain) and a-smooth muscle actin expression (red stain) in human mature
kidney. In the arterial media a-smooth muscle actin but not PDGF
a-receptor is expressed. In the interstitium most PDGF a-receptor
positive cells do not express a-smooth muscle actin, but some double
labeling can be noted in myofibroblasts (top right corner) (magnification
><400). B. Double immunolabehing for PDGF a-receptor expression
(brown stain) and binding of Ulex europeaus (dark purple stain) in human
mature kidney. Interstitial cells expressing PDGF a-receptor (arrows) are
negative for Ulex europeaus binding (x400).
C 
0) 
I
______
7.3 :aai¼
c4
'4
1146 Floege et al: PDGF a-receptor in human kidney
50°C. After hybridization, sections were washed with 0.5 X SSC,
treated with RNase A (20 tgIml, 30 mm room temperature),
washed in 2 x SSC (2 X 2 mm), followed by three high-stringency
washes in 0.1 x SSC/Tween 20 (Sigma) at 37°C, and several 2 X
SSC washes. After the tissue was dehydrated and air dried, it was
dipped in NTB2 nuclear emulsion (Kodak, Rochester, NY, USA)
and exposed in the dark at 4°C for two weeks. After developing,
the sections were counterstained with hematoxylin and eosin,
dehydrated, mounted and viewed. Positive cellular labeling was
defined as five or more silver grains concentrated over a single
cell.
Results
Antibody characterization
Usage of the four different antibodies against PDGF a-receptor
generally yielded similar staining patterns (see below) under the
various tissue storage and fixation conditions described in the
Methods section. In single specimens or under particular staining
conditions, we occasionally observed irregular staining of tubular
cells in mature and fetal kidneys or visceral glomerular epithelial
cells in some fetal kidneys. Given the inconsistency of these
findings and the lack of corresponding observations during in situ
hybridization, we considered them to represent nonspecific stain-
ing. However, we cannot fully exclude that in some of the
locations, PDGF a-receptor antigen or cross reacting antigens
may have been detected by the various antibodies. Since the
polyclonal PDGF (R)-A 951 (Santa Cruz Biotechnology) antibody
yielded the most consistent results and reacted with the antigen in
paraffin-embedded sections, that is, provided better morphologi-
cal resolution, we chose this antibody for an extended study.
Western blotting using the PDGF (R)-A 951 antibody detected
a single 180 kDa band, corresponding to the 180 kDa PDGF
a-receptor, in growth arrested human lung fibroblasts (Fig. 1).
Following a six hour pretreatment with PDGF-AA, the fibroblast
expression of the PDGF a-receptor was greatly diminished (Fig.
1). In contrast, no PDGF a-receptor expression could be detected
in lysates of fetal or mature arterial smooth muscle cells or
neonatal microvascular endothelial cells (both under conditions of
growth arrest and FCS-induced proliferation; Fig. 1).
Fetal kidneys
The overall morphology of the fetal kidneys as observed during
light microscopy corresponded to that described previously [161.
Immunohistochemical findings and the findings of in situ hybrid-
ization in the fetal kidneys are summarized in Table 1.
1mmunohistochemisty
As shown in Figure 2 A and B, expression of PDGF a-receptor
protein was not observed in cells of the undifferentiated meta-
nephric blastema or glomerular vesicles. However, within the
metanephric blastema, positive staining for PDGF a-receptor was
noted in the vascular arcades that course through these regions
(Fig. 2 A, B). Specific identification of the cell type expressing this
molecule was not achieved. PDGF a-receptor was occasionally
expressed in the invaginating mesangium or the hilar or stalk
region of early glomerular differentiation stages, such as the
comma or S-stage (Fig. 2 B, C). In some cases the invaginating
PDGF a-receptor expressing cells were in unbroken continuity
with the vascular arcades coursing down from the blastemal
region. In differentiated glomeruli, positive staining for PDGF
a-receptor was largely lost. No staining of tubular cells or cells of
the ureteric bud could be demonstrated (Fig. 2 A-C). However,
outside of the metanephric blastema, we frequently noted a
staining pattern which was reminiscent of tubular basement
membrane staining and staining of the glomerular capsule (Fig. 2
B-C). Whether this staining indeed represented basement mem-
brane staining or staining of interstitial fibroblast extensions could
not be resolved at the light microscopic level. PDGF a-receptor
was uniformly expressed in interstitial cells in all specimens (Fig.
2 A-D). Strong staining was also observed in the adventitia of the
fetal arterial vasculature, while staining was negative or trace in
the media and absent in intimal cells (Fig. 2E). In occasional large
vessels, apparent staining of the internal elastic membrane was
noted (Fig. 2E). As in the case of the tubular basement mem-
brane, we were unable to determine by light microscopy whether
this latter staining was extracellular or staining of cellular exten-
sions.
In situ hybridization
PDGF a-receptor mRNA was not detected in cells of the
undifferentiated metanephric blastema or glomerular vesicles but
was notably present in the vascular arcades coursing through the
blastema (Fig. 3 A, B). At later stages of glomerular development
(comma or S-stage), positive signal could be detected in the
glomerular mesangial areas and hilar regions (Fig. 3 D, E). This
signal was largely lost in differentiated glomeruli, in which only
rare cells in mesangial areas expressed PDGF a-receptor mRNA
(Fig. 3 D, E). No signal overlying glornerular visceral or epithelial
cells was noted. Tubular cells and ureteric buds consistently failed
to express PDGF a-receptor mRNA, while in all specimens the
surrounding interstitial cells as well as cells comprising the
vascular adventitia showed a strong hybridization signal (Fig. 3 F,
G). Other vascular cells, such as those of the arterial media or
intima were negative by in situ hybridization (Fig. 3 F, G).
Mature kidneys
Immunohistochemical findings and the findings of in situ hy-
bridization in the mature kidneys are summarized in Table 2.
Immunohistochemistiy
As shown in Figure 4 A and B, PDGF a-receptor staining in
glomeruli was detectable in a small minority of the glomeruli
examined. Such glomeruli were occasionally encountered in 70%
of the kidney specimens examined; the remaining specimens had
no glomerular staining whatsoever. Glomerular staining was
confined to mesangial areas. Visceral or parietal glomerular
epithelial cells consistently failed to exhibit positive staining for
PDGF a-receptor. Tubular staining was also generally absent at
the antibody concentrations employed (Fig. 4 A and B). In the
renal interstitium, PDGF a-receptor was constitutively expressed
in all specimens, both in the cortex and medulla (Fig. 4 A-C).
PDGF a-receptor expression was particularly prominent around
vessels and in the adventitia of small arteries. Also, in rare
instances, a staining pattern reminiscent of tubular basement
membrane staining or of the glomerular capsule (similar to that in
fetal kidneys and shown in Fig. 2 A-C) was present. Within the
media of small arteries, most cells were not stained, but rare
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50°C. After hybridization, sections were washed with 0.5 X SSC,
treated with RNase A (20 rg/ml, 30 mm room temperature),
washed in 2 x SSC (2 X 2 mm), followed by three high-stringency
washes in 0.1 X SSC/Tween 20 (Sigma) at 37°C, and several 2 ><
SSC washes. After the tissue was dehydrated and air dried, it was
dipped in NTB2 nuclear emulsion (Kodak, Rochester, NY, USA)
and exposed in the dark at 4°C for two weeks. After developing,
the sections were counterstained with hematoxylin and eosin,
dehydrated, mounted and viewed. Positive cellular labeling was
defined as five or more silver grains concentrated over a single
cell.
Results
Antibody characterization
Usage of the four different antibodies against PDGF a-receptor
generally yielded similar staining patterns (see below) under the
various tissue storage and fixation conditions described in the
Methods section. In single specimens or under particular staining
conditions, we occasionally observed irregular staining of tubular
cells in mature and fetal kidneys or visceral glomerular epithelial
cells in some fetal kidneys. Given the inconsistency of these
findings and the lack of corresponding observations during in Situ
hybridization, we considered them to represent nonspecific stain-
ing. However, we cannot fully exclude that in some of the
locations, PDGF a-receptor antigen or cross reacting antigens
may have been detected by the various antibodies. Since the
polyclonal PDGF (R)-A 951 (Santa Cruz Biotechnology) antibody
yielded the most consistent results and reacted with the antigen in
paraffin-embedded sections, that is, provided better morphologi-
cal resolution, we chose this antibody for an extended study.
Western blotting using the PDGF (R)-A 951 antibody detected
a single 180 kDa band, corresponding to the 180 kDa PDGF
a-receptor, in growth arrested human lung fibroblasts (Fig. 1).
Following a six hour pretreatment with PDGF-AA, the fibroblast
expression of the PDGF a-receptor was greatly diminished (Fig.
1). In contrast, no PDGF a-receptor expression could be detected
in lysates of fetal or mature arterial smooth muscle cells or
neonatal microvascular endothelial cells (both under conditions of
growth arrest and FCS-induced proliferation; Fig. 1).
Fetal kidneys
The overall morphology of the fetal kidneys as observed during
light microscopy corresponded to that described previously [16].
Immunohistochemical findings and the findings of in situ hybrid-
ization in the fetal kidneys are summarized in Table 1.
Immunohistochemistiy
As shown in Figure 2 A and B, expression of PDGF a-receptor
protein was not observed in cells of the undifferentiated meta-
nephric blastema or glomerular vesicles. However, within the
metanephric blastema, positive staining for PDGF a-receptor was
noted in the vascular arcades that course through these regions
(Fig. 2 A, B). Specific identification of the cell type expressing this
molecule was not achieved. PDGF a-receptor was occasionally
expressed in the invaginating mesangium or the hilar or stalk
region of early glomerular differentiation stages, such as the
comma or S-stage (Fig. 2 B, C). In some cases the invaginating
PDGF a-receptor expressing cells were in unbroken continuity
with the vascular arcades coursing down from the blastemal
region. In differentiated glomeruli, positive staining for PDGF
a-receptor was largely lost. No staining of tubular cells or cells of
the ureteric bud could be demonstrated (Fig. 2 A-C). However,
outside of the metanephric blastema, we frequently noted a
staining pattern which was reminiscent of tubular basement
membrane staining and staining of the glomerular capsule (Fig. 2
B-C). Whether this staining indeed represented basement mem-
brane staining or staining of interstitial fibroblast extensions could
not be resolved at the light microscopic level. PDGF a-receptor
was uniformly expressed in interstitial cells in all specimens (Fig.
2 A-D). Strong staining was also observed in the adventitia of the
fetal arterial vasculature, while staining was negative or trace in
the media and absent in intimal cells (Fig. 2E). In occasional large
vessels, apparent staining of the internal elastic membrane was
noted (Fig. 2E). As in the case of the tubular basement mem-
brane, we were unable to determine by light microscopy whether
this latter staining was extracellular or staining of cellular exten-
sions.
In situ hybridization
PDGF a-receptor mRNA was not detected in cells of the
undifferentiated metanephric blastema or glomerular vesicles but
was notably present in the vascular arcades coursing through the
blastema (Fig. 3 A, B). At later stages of glomerular development
(comma or S-stage), positive signal could be detected in the
glomerular mesangial areas and hilar regions (Fig. 3 D, E). This
signal was largely lost in differentiated glomeruli, in which only
rare cells in mesangial areas expressed PDGF a-receptor mRNA
(Fig. 3 D, E). No signal overlying glomerular visceral or epithelial
cells was noted. Tubular cells and ureteric buds consistently failed
to express PDGF a-receptor mRNA, while in all specimens the
surrounding interstitial cells as well as cells comprising the
vascular adventitia showed a strong hybridization signal (Fig. 3 F,
G). Other vascular cells, such as those of the arterial media or
intima were negative by in situ hybridization (Fig. 3 F, G).
Mature kidneys
Immunohistochemical findings and the findings of in situ hy-
bridization in the mature kidneys are summarized in Table 2.
Immunohistochemistiy
As shown in Figure 4 A and B, PDGF a-receptor staining in
glomeruli was detectable in a small minority of the glomeruli
examined. Such glomeruli were occasionally encountered in 70%
of the kidney specimens examined; the remaining specimens had
no glomerular staining whatsoever. Glomerular staining was
confined to mesangial areas. Visceral or parietal glomerular
epithelial cells consistently failed to exhibit positive staining for
PDGF a-receptor. Tubular staining was also generally absent at
the antibody concentrations employed (Fig. 4 A and B). In the
renal interstitium, PDGF a-receptor was constitutively expressed
in all specimens, both in the cortex and medulla (Fig. 4 A-C).
PDGF a-receptor expression was particularly prominent around
vessels and in the adventitia of small arteries. Also, in rare
instances, a staining pattern reminiscent of tubular basement
membrane staining or of the glomerular capsule (similar to that in
fetal kidneys and shown in Fig. 2 A-C) was present. Within the
media of small arteries, most cells were not stained, but rare
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Fig. 6. Demonstration of PDGF a-receptor mRN.4 in human mature kidney by in situ hybridization. A and B. Most interstitial cells express PDGF
a-receptor mRNA, while no significant hybridization signal is observed in the glomerulus or tubular cells (magnification X400). C and D. At the other
end of the spectrum, occasional glomeruli showed mild and even moderate expression of PDGF a-receptor mRNA, as demonstrated in this glomerulus
(x400). E and F. In an arterial vessel, adventitial cells express PDGF a-receptor mRNA, while no significant signal is present in the intima or media
(m) (X400).
weakly stained cells could be observed (Fig. 4C). No PDGF
a-receptor expression was detectable on vascular endothelial cells
or in the area of the internal elastic membrane of arterial vessel
walls (Fig. 4C).
Expression of a-smooth muscle actin in normal mature kidney
was similar to that described previously in that vascular smooth
muscle cells stained positive as did occasional cells in mesangial
areas and some interstitial cells and [31]. Double immunostaining
for a-smooth muscle actin and PDGF a-receptor revealed occa-
sional doubly labeled cells in mesangial and interstitial locations,
while the large majority of a-smooth muscle actin positive vascu-
lar smooth muscle cells failed to express the PDGF a-receptor
(Fig. 5A).
Ulex europeaus lectin bound to endothelial cells of all vessels,
collecting ducts and erythrocytes, similar to previous descriptions
[16, 28, 29]. In this case double immunostaining for Ulex europe-
aus and PDGF a-receptor failed to show co-localization of the
two antigens (Fig. 5B).
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In situ hybridization
No or only weak expression of PDGF a-receptor mRNA was
detectable in most glomeruli of 7 of 15 (47%) of the specimens
examined (Fig. 6 A, B). In the remaining eight specimens a weak
to moderate signal was sometimes noted within the glomerular
tuft (Table 2). As in the case of immunohistochemistry, PDGF
a-receptor mRNA expression by visceral or parietal glomerular
epithelial cells was not observed. Tubular cells consistently failed
to show hybridization with the probe (Fig. 6 A, B). In the cortical
and medullary interstitium, expression of PDGF a-receptor
mRNA was always detectable but was focal and ranged from
absent to strong within all specimens (Fig. 6 A, B). Small arteries
exhibited weak to moderate hybridization in the adventitia but no
detectable PDGF a-receptor mRNA expression by medial or
intimal cells (Fig. 6 C, D).
Discussion
In both developing and mature human kidneys, immunohisto-
chemistry with four different antibodies against the PDGF a-re-
ceptor, as well as in situ hybridization for PDGF a-receptor
mRNA, consistently demonstrated prominent synthesis and ex-
pression of the receptor in interstitial fibroblasts. A second cell
type expressing PDGF a-receptor, albeit to a lower and more
variable extent than fibroblasts, were glomerular mesangial cells,
in particular the probable mesangial cell precursors in fetal
kidneys. Possible expression of the receptor was identified in a
third mesenchymal cell type, vascular smooth muscle cells, but at
an even lower and more variable degree than in mesangial cells.
PDGF a-receptor was also detected in the vascular arcades of the
fetal metanephric blastema, but it is not certain which cell type
expressed the receptor in these early vessels. In contrast to these
cell types, we found no conclusive evidence for expression of
PDGF a-receptor mRNA or protein in glomerular epithelial cells,
tubular cells or endothelial cells of large intrarenal vessels or the
microvasculature in fetal and mature kidney. Finally, by immuno-
cytochemistry we noted occasional staining along the tubular
basement membrane, the glomerular capsule and the internal
elastic membrane of large vessels, which were more common in
fetal than in mature kidney. Light microscopy did not allow us to
localize these sites of receptor expression to extracellular struc-
tures with certainty. However, the findings could conceivably
PDGFRf3 relate to circulating extracellular domains of the PDGF a-recep-
tor [321 binding to extracellular matrix proteins.
+ Gesualdo et a! [23] have recently analyzed the expression of
+ PDGF a-receptor protein in frozen sections of normal mature
+ human kidneys. They reported but did not illustrate receptor
protein expression in interstitial fibroblasts and mesangial areas as
well as in glomerular epithelial cells. By in situ hybridization, again
+ performed on frozen tissue, PDGF a-receptor mRNA localized
+ prominently to mesangial, to a lower degree to interstitial areas
+ and apparently also to glomerular epithelial cells [23]. Vascular
—
expression of PDGF a-receptor was not described. Apart from the
+ findings in glomerular epithelial cells, the data of Gesualdo et a!
— [23] and those of the present study are qualitatively similar. On a
+ quantitative basis the two studies differ in that we regularly
+ observed stronger expression of PDGF a-receptor mRNA and
protein in interstitial as compared to mesangial areas. In a second
recent study, Stein-Oakley et a! [24] described their failure to
detect any renal expression of PDGF a-receptor in frozen biop-
sies from eight normal mature human kidneys. In the light of our
data and those of Gesualdo et al [23], these findings possibly
represent a technical limitation, since that study exclusively relied
on immunohistochemistry with a single antibody.
Our findings are corroborated by a variety of in vitro observa-
tions: Cultured fibroblasts of dermal and pulmonary origin ex-
press PDGF a-receptor and respond to stimulation with PDGF
AA [33—371, but cultured renal fibroblasts have not been investi-
gated so far. In isolated rat glomeruli, PDGF a-receptor mRNA
and protein could not be detected [15], but cell culture studies
have demonstrated the ability of human and rat mesangial cells to
synthesize PDGF a-receptor [3, 4, 38]. Finally, expression of
PDGF a-receptor and/or responsiveness to PDGF-AA has also
been noted in macrovascular arterial and venous smooth muscle
cells [37, 39—41]. However, in all three cell types, that is,
fibroblasts, mesangial cells and smooth muscle cells, the responses
of smooth muscle cells to PDGF-AA have been variable, ranging
from absent to pronounced [3, 4, 33, 34, 37, 39—42]. These latter
findings likely result from the fact that PDGF a-receptor expres-
sion is highly regulated via many factors, including endogenous
PDGF A-chain production, cytokines, lipopolysaccharide and
cx2-macroglobulin [3, 33, 34, 37, 38, 40, 43]. These in vitro data can
also explain some of the variability of our mesangial PDGF
a-receptor expression in vivo, and in particular the in vitro data
showing PDGF a-receptor synthesis in vascular smooth cells but
little or no expression in normal vascular smooth muscle cells in
vivo.
Responsiveness of human glomerular epithelial cells or tubular
cells to PDGF AA, implying the presence of a-receptors, has not
been described so far. In agreement with our in vivo observations,
most investigators have also failed to demonstrate PDGF a-re-
ceptors available for PDGF AA-responsiveness on endothelial
cells [44, 45]. However, others have reported that PDGF a-recep-
tor expression can occur on rat micro- or macrovascular endothe-
hal cells under cell culture conditions mimicking injury [46] or
following endothelial injury in vivo [47]. Consequently, we cannot
exclude that human renal endothehial cells possess the ability to
synthesize PDGF a-receptors, since under normal conditions the
receptors may either not be expressed or expression may be below
the detection threshold of immunocytochemistry and in situ
Table 3. Comparative expression of PDGF a and 13 in developing and
mature kidney
PDGFRS
Developing kidney
Metanephric blastema
Early mesangial structures
Differentiated mesangium
Glomerular epithelial cells
Glomerular endothelial cells
Tubules
Interstitial cells
Vascular adventitial cells
Vascular arcades
Ureteric buds
Mature kidney
Glomerular mesangium
Visceral epithehium
Parietal epithelium
Interstitial cells
Vascular adventitial cells
Tubules
+
+
+
+
occasional +
+
+
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hybridization. The potential de nova expression or up-regulation
of PDGF a-receptors on human renal endothelial cells following
injury might be of pathophysiological importance, given that
neointimal smooth muscle cells and injured endothelium produce
PDGF A-chain [12, 22, 47, 48], that is, paracrine and autocrine
loops would be constituted.
The functional relevance of renal PDGF a-receptor expression,
as of renal PDGF A-chain production, is largely undefined. Mice
genetically deficient for the PDGF A-chain showed a defective
pulmonary alveolar myofibroblast development and died either
prenatally or within 60 days after birth of emphysema [49].
Kidneys and the renal vasculature developed a normal morphol-
ogy (C.E. Alpers, unpublished observation). Similarly, PDGF
a-receptor knockout mice demonstrated no gross morphological
abnormalities in their kidneys (P. Soriano, personal communica-
tion). Thus, the lack of signalling via the PDGF a-receptor in
these mice apparently is compensated by PDGF-independent
pathways [50].
In the mature kidney, the constitutive and ubiquitous expres-
sion of the receptor on renal interstitial cells suggests that it might
contribute to the pathogenesis of renal fibrosis, the common final
pathway of progressive renal diseases. In lung fibroblasts, in
particular those stimulated with endotoxin, PDGF a-receptors
mediate mitogenic and chemotactic responses [33], supportive of
a potential role in fibrogenesis. The developmental abnormalities
of pulmonary myofibroblasts in PDGF A-chain knockout mice
[49] further strengthen this assumption. Similar to fibroblasts,
mesangial cells can exhibit a proliferative response to PDGF-AA
[3, 4] and PDGF A-chain is overexpressed in glomeruli during
mesangioproliferative nephritis [15], suggesting a possible in-
volvement of the a-receptor in mesangioproliferative diseases.
Finally, in smooth muscle cells, stimulation with PDGF-AA also
results in chemotaxis, hyperplasia and/or hypertrophy [42, 43, 51].
A third potential role of renal PDGF a-receptors may thereby lie
in the pathogenesis of vascular sclerosis and/or renal transplant
rejection.
A noteworthy finding in this study were both the differences and
similarities observed between localization of PDGF a-receptor
and that of PDGF /3-receptor, the only receptors known to bind
PDGF. As previously detailed [10, 16] and summarized in Table 3,
PDGF /3-receptor is present in metanephric blastema, interstitial
cells, mesangial cells, and adventitial cells in developing human
kidneys, and in mesangial areas, parietal epithelial cells, intersti-
tial cells, and vascular adventitial cells in the mature kidney.
PDGF a-receptor co-localizes with PDGF /3-receptor in intersti-
tial cells and adventitial cells in the developing and mature kidney.
As we have demonstrated in this study, prominent expression of
PDGF a-receptor by more differentiated mesangial cells is not
seen in the developing kidneys, and only focal, generally low levels
of this receptor are detected in mature mesangial cells of unin-
jured human glomeruli. Prominent expression of PDGF a-recep-
tor by the metanephric blastema is also not apparent, although it
is expressed by cells that comprise at least in part the vascular
arcades that course through this tissue compartment. Neither
PDGF a-receptor nor PDGF /3-receptor are present in the
ureteric bud structures.
In summary, the current study shows widespread expression of
PDGF a-receptor in fetal and mature renal fibroblasts and
developing renal vessels as well as lesser degrees of expression in
glomerular mesangial cells. Although yet undefined, this location
of the receptor suggests roles in renal development and in the
pathogenesis of renal fibrosis, mesangioproliferative diseases, and
vascular diseases. The present study, which completes the local-
ization of the normal and developing human renal PDGF ligand
and receptor system [10, 16—19, 22, 23], lays the basis for further
investigations in renal diseases and for functional studies on the
role of the PDGF a-receptor in the kidney.
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